OverviewChartTechnicalNews
Derivatives
TraderScreen

Royalty Pharma PLC/  GB00BMVP7Y09  /

NASDAQ
2024-09-25  10:00:00 PM Chg. -0.0600 Volume Bid11:39:12 PM Ask11:39:12 PM High Low
27.6500USD -0.22% 1.69 mill.
Turnover: 28.2 mill.		 27.6100Bid Size: 100 28.5800Ask Size: 100 27.8700 27.5800
GlobeNewswire 08-28 Royalty Pharma to Present at Morgan Stanley’s 22nd Annual Global Healthcare Conference
GlobeNewswire 08-08 Cytokinetics Reports Second Quarter 2024 Financial Results
GlobeNewswire 08-08 Royalty Pharma Reports Second Quarter 2024 Results
GlobeNewswire 08-06 Agios to Receive $1.1 Billion in Milestone Payments Following FDA Approval of Vorasidenib
GlobeNewswire 08-01 Agios Reports Business Highlights and Second Quarter 2024 Financial Results
GlobeNewswire 07-24 Royalty Pharma Appoints Molly Sawaya as Executive Vice President, Head of Human Capital
GlobeNewswire 07-19 Royalty Pharma to Announce Second Quarter 2024 Financial Results on August 8, 2024
GlobeNewswire 07-17 Royalty Pharma Declares Third Quarter 2024 Dividend
Newsfile Corp 07-17 Analysts Hunt for Undervalued Biotech Stocks
GlobeNewswire 06-04 Royalty Pharma to Present at the Goldman Sachs 45th Annual Global Healthcare Conference
GlobeNewswire 06-03 Royalty Pharma Announces Pricing of $1.5 Billion of Senior Unsecured Notes
GlobeNewswire 05-28 Royalty Pharma and Agios Pharmaceuticals Enter Into Vorasidenib Royalty Agreement for $905 Million
GlobeNewswire 05-28 Agios Announces $905 Million Purchase Agreement for Vorasidenib Royalty
GlobeNewswire 05-22 Royalty Pharma and Cytokinetics Announce Expanded Strategic Funding Collaboration Totaling Up to $57...
GlobeNewswire 05-22 Cytokinetics and Royalty Pharma Announce Expanded Strategic Funding Collaboration Totaling Up to $57...
GlobeNewswire 05-13 Royalty Pharma to Present at Upcoming Investor Conferences
GlobeNewswire 05-09 Royalty Pharma Reports First Quarter 2024 Results
GlobeNewswire 05-09 Royalty Pharma to Acquire Royalty Interest in Sanofi’s Frexalimab
GlobeNewswire 05-08 Cytokinetics Reports First Quarter 2024 Financial Results
GlobeNewswire 04-19 Royalty Pharma to Announce First Quarter 2024 Financial Results on May 9, 2024
GlobeNewswire 04-17 Royalty Pharma Declares Second Quarter 2024 Dividend
GlobeNewswire 02-28 Royalty Pharma to Present at TD Cowen’s 44th Annual Health Care Conference
GlobeNewswire 02-27 Cytokinetics Reports Fourth Quarter 2023 Financial Results
GlobeNewswire 02-15 Royalty Pharma Reports Q4 and Full Year 2023 Results
GlobeNewswire 01-30 Royalty Pharma To Announce Fourth Quarter And Full Year 2023 Financial Results On February 15, 2024